Current therapeutic strategies for SOD1-related ALS aim to mitigate toxic protein aggregates and misfolded proteins through approaches such as lowering SOD1 levels, RNA interference (RNAi), antibody therapies, and genome editing techniques. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.